Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy (PRIMHER)

Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica

Status: Completed

Conditions: Disseminated HER2+ Breast Cancer

Study type: Observational

Funder types: NETWORK

Identifiers

NCT01645059

ACI-CMM-2010-01

Details and patient eligibility

About

This is an observational, cross-sectional study that the main objective is to describe the patient clinical profile that begins with disseminated Her 2+ Breast Cancer or develops a metastasis after or during the adjuvant treatment.

Enrollment: 129 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women with 18 years or over
• Patients with disseminated breast cancer histologically or cytological confirmed, who begins with Her 2+ metastatic breast cancer or develops a metastasis after or during the adjuvant therapy
• Patients treated in first line treatment in metastatic disease.
• Patients who have positive Her 2 receptor test
• Patients who have given their written informed consent

Exclusion criteria

• Patients who are participating in other studies